Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Convenia   
Auth. number : EU/2/06/059
INN : Cefovecin
ATC: Anatomical main group: QJ - Antiinfectives for systemic use
Therapeutic subgroup: QJ01 - Antibacterials for systemic use
Pharmacological subgroup: QJ01D - Other beta-lactam antibacterials
Chemical subgroup: QJ01DD - Third-generation cephalosporins
Chemical substance: QJ01DD91 - Cefovecin
(See WHO ATCvet Index)
Indication: Target species Dogs and cats.For use only for the following infections which require prolonged treatment. The antimicrobial activity of Convenia following a single injection lasts for up to 14 days.Dogs:For the treatment of skin and soft tissue infections including pyoderma, wounds and abscesses associated with Staphylococcus pseudintermedius, β-haemolytic Streptococci, Escherichia coli and/or Pasteurella multocida.For the treatment of urinary tract infections associated with Escherichia coli and/or Proteus spp. As adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with Porphyromonas spp. and Prevotella spp.Cats:For the treatment of skin and soft tissue abscesses and wounds associated with Pasteurella multocida, Fusobacterium spp., Bacteroides spp., Prevotella oralis, b haemolytic Streptococci and/or Staphylococcus pseudintermedius.For the treatment of urinary tract infections associated with Escherichia coli.
Marketing Authorisation Holder: Zoetis Belgium S.A.
Rue Laid Burniat 1, 1348 Louvain-La-Neuve, Belgique

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/06/2006 Centralised - Authorisation EMEA/V/C/98 (2006)2890 of 19/06/2006
05/06/2008 Centralised - Variation EMEA/V/C/98/II/2 (2008)2531 of 03/06/2008
25/06/2008 Centralised - Variation EMEA/V/C/98/II/1
17/09/2008 Centralised - Variation EMEA/V/C/98/IB/4
20/10/2008 Centralised - Variation EMEA/V/C/98/II/5
23/10/2008 Centralised - Variation EMEA/V/C/98/II/3 (2008)6251 of 22/10/2008
25/06/2009 Centralised - Variation EMEA/V/C/98/IA/8
Updated with Decision(2010)188 of 15/01/2010
17/08/2009 Centralised - Variation EMEA/V/C/98/IB/7
Updated with Decision(2010)188 of 15/01/2010
30/10/2009 Centralised - Variation EMEA/V/C/98/II/9
19/01/2010 Centralised - Variation EMEA/V/C/98/II/6 (2010)188 of 15/01/2010
23/07/2010 Centralised - Variation EMEA/V/C/98/II/10
27/09/2010 Centralised - Variation EMEA/V/C/98/IB/11
Updated with Decision(2011)2802 of 14/04/2011
20/04/2011 Centralised - Variation (2011)2802 of 14/04/2011
17/06/2011 Centralised - Renewal EMEA/V/C/98/R/12 (2011)4348 of 15/06/2011
30/05/2012 Centralised - Variation EMEA/V/C/98/II/16 (2012)3469 of 22/05/2012
22/05/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/98/T/19 (2013)2991 of 16/05/2013
05/09/2013 Centralised - Variation EMEA/V/C/98/IA/20